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ABSTRACT
HYPERCHOLESTEROLEMIA AND PLATELET SENSITIVITY TO
THROMBIN-INDUCED AGGREGATION IN WHOLE BLOOD
Charles E. Hammond, I I, M. s.
Morehead State University, 1989

Hypercholesterolemla Is a risk factor which Is
associated with an Increased Incidence of cardiovascular
disease.

Hypercholesterolemla Is correlated with the

formation of atherosclerotlc lesions which result In
lschemla of vital tissues.
In the normal hemostatlc response, platelets respond
to a variety of activating molecules which facl I ltate
their aggregation at sites of Injury to the vessel wal I.
In hypercholesterolemlc lndlvlduals, there Is an altered
physiology of the endothel lal
of blood platelets.

I In Ing of blood vessels and

This physiological change Is

bel leved to result In a response-to-Injury reaction at
the vessel wal I.

The biochemical

Injury Is thought to be

Induced by high levels of LDL cholesterol

In the plasma.

High levels of LDL cholesterol are positively correlated
with changes In the I lpld composition of the membranes
of platelets and endothel lal eel Is.
These changes are also correl~ted with an Increased
sensitivity of Isolated, washed platelets to thrombln
binding.

However, an Increased platelet sensitivity to
I I I

thrombln has never been documented In whole blood
studies.

It has also been found that other types of

blood eel Is participate physical Jy and biochemical Jy with
platelets In the aggregation process.

Therefore, this

study focused on changes In platelet sensitivity to
thrombln-lnduced aggregation In whole blood, as measured
In a whole blood Impedance aggregometer.
Hypercholesterolemla was Induced In rats fol lowing 8
weeks of a high cholesterol di.et containing 5%
cholesterol and

1%

sodium taurocholate.

The attainment

of high levels of plasma cholesterol were confirmed at
this time by performing enzymatic assays on plasma
derived from the animals' blood.

Fol lowing

8

weeks of

this diet, aggregometry measurements were taken from
the·Jr whole blood and compared with results from a normal
diet group of rats.

A

0.15

unit threshold of thrombln

Induced aggregation In the whole blood of 70% of the high
cholesterol diet group, whl le this same level of thrombln
only Induced aggregation In the whole blood of 20% of the
normal diet group.

The reduced threshold of the high

cholesterol diet group was associated with an Increase In
plasma levels of total cholesterol and LDL cholesterol,
cholesterol, and a decreased level of HDL cholesterol.
The high cholesterol diet group's blood showed a
significantly greater maximal
Iv

Increase In Impedance (p

<

0.05)

In response to the addition of 0.15 units of

thrombln than occurred In blood from the normal diet
group.

The high cholesterol diet group's platelets also

aggregated at a significantly faster rate (p

<

0.025)

than did the platelets from the normal diet group.
Therefore the hypercholesterolemla dl·d have a role
In altering the sensitivity of platelets to thromblnlnduced aggregation.
provides additional

It

Is hoped that this study

Insight

Into the role of platelets In

atherogenesls.
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LITERATURE REVIEW

INTRODUCTION:
Cardiovascular disease Is the number one cause of
death In the United States.

The primary cause of

cardiovascular disease Is atherosclerosis, a thickening
of the vessel wal I which can obstruct the flow of
arterial blood, resulting In lschemla of heart, brain or
other organs.
the Individual.

This lschemla often leads to the death of
A number of factors which can contribute

to the formation of atherosclerotlc lesions have been
Identified, and these are usually associated with
I I festy I es or d I seases,

Inc I ud Ing smok Ing, d I abetes

mel I ltus, hypercholesterolemla, and hypertension (Ross,
1 986) .

Changes In the proteins of the vessel wal I have
been shown to occur as a direct result of prolonged
hyperg I ycem I a.

It has been hypothes I zed that, as a

result of these changes, a chain of events leading to
atherosclerosis often occurs (Cerami et al, 1987).
The Incidence of high levels of blood cholesterol,
mainly low-density-I lpoproteln (LDL) cholesterol, has
been shown to be a maJor contributor to atherosclerotlc
plaque formation (Lipid Research Cl lnlcs Program, 1984).
A high blood cholesterol

level, or hypercholesterolemla,
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often results from the habitual

Ingestion of foods which

are rich In cholesterol, although there are some
Individuals who develop hypercholesterolemla due to a
genetic deficiency of low-density-I lpoproteln receptors
(Goldstein & Brown, 1983).

Most cases of

hypercholesterolemla are related to diet, and one recent
estimate Is that-36% of al I American adults are
cand I dates for med I ca I I ntervent I on to prevent
cardiovascular disease (Sempos et al, 1989).

In order to

understand how hypercholesterolemla can lead to the
formation of atherosclerotlc lesions, we must discover
how cholesterol and other factors affect the types of
eel Is which are Involved In arterial

lesions.

Normally, the arterial wal I consists of a single,
Internal

layer (tunlca Int Ima) of flat endothel Jal eel Is

overlying a thin basal
tissue.

lamina consisting of connective

Within the basal

monocytes or macrophages.

lamina are smal I numbers of
These are bel leved to serve In

a scavenger capacity for the removal of blood
cholesterol, which Is absorbed by endothel lal eel Is and
transcytosed to the underlying monocytes (Steinberg,
1987).

Smooth muscle eel Is are the predominant eel I type

of the next layer, or tunlca media.

The third arterial

layer Is the tunlca adventltla, which consists mostly of
connective tissue.
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In a microscopic cross-section of an atherosclerotlc
artery, the most obvious characteristic differentiating
It from a normal artery Is a massive prof Jferatlon of
smooth muscle eel Is In the tun lea Int Ima.

The Jntlma

wl I I also have an Increased amount of lntracel Jular and
extracellular I Jpld.

This type of lesion can develop

over a number of years, beginning In childhood In humans.
In the arteries of children, macroscopic structures known
as fatty streaks are common. They consist of Increased
amounts of I Jpld, macrophages and smooth muscle eel Is In
the Int Ima, directly underneath the endothel Jal
These appear In the same areas which,

I In Ing.

In later I lfe, have

a high Incidence of atherosclerotlc lesions.

Animal

studies have supported the theory that the fatty streaks
are the early stages of atherosclerosis (Ross, 1986).

THE RESPONSE-TO-INJURY HYPOTHESIS:

Atherosclerotlc lesion formation Is associated with
hypercholesterolemla and a number of other risk factors.
Bal loon angioplasty of arteries, which can remove the
endothe I I a I I In Ing of the artery In the area where the
procedure Is performed, has provided Information relating
a role for physical

Injury to endothel lum In

atherogenesls.
When the endothel !al

layer Is removed from the
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Int Ima, the subendothe I I a I I ayer Is exposed to the b I ood,
and blood platelets quickly attach to exposed collagen
fibers and monocytes and release a number of products,
Including platelet-derived growth factor (PDGF).

PDGF

Induces blood monocytes to migrate Into the Int Ima and
differentiate Into macrophages, white blood eel Is which
usually migrate Into Injury sites, acting as phagocytes
to destroy Invading bacteria.

As these macrophages

become situated under and between endothel lal eel Is, they
become swol fen with cholesterol.
The PDGF also acts upon the smooth muscle eel Is of
the tunlca media,

Inducing their prol lferatlon In the

subendothe I I a I I ayer.

The Increased vo I ume of ce I Is

be I ow the endothe I I a I I ayer can pro I I fer ate,
marked stenosls of the arterial

lumen.

I ead Ing to a

such a stenosls

In a coronary artery can I ead to myocard I a I In far ct I on.
PDGF Is prob ab I y not on I y produced by p I ate I ets.

It

has been found that agents which strongly resemble PDGF
are produced by endothei ial eel Is and macrophages.
Endothelium production of the PDGF-1 Ike mltogen Is
enhanced when Its eel iular overturn Is Increased In such
situations as the loss of a smal I number of adjacent
eel Is In the int Ima.

In smai I,

localized Injury sites,

the endothe I I um Is ab I e to overcome such sma I I I osses
quickly through mitotic replacement.

This mitotic
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overturn .!...!l vivo Is normally very slow.

However, when

monocultures of endothel lal eel Is are grown, their
overturn rate Is sl lghtly Increased, with a concomitant
Increase In the production of the mltogen.

It Is

therefore thought that endothel !al eel Is growing In an
artificial culture exist In a state resembl Ing eel Is
which have been continua I Iy exposed to an Injury, thus
they produce the PDGF-1 Ike mltogen In response (Ross,
1986).

It has been proposed that hypercholesterolemla can
Induce In endothel lal eel Is a continual state of
biochemical

Injury In which the Integrity of the eel Is'

physiology Is somehow compromised,

leadlng to the release

of chemoattractants which cause an Increased number of
macrophages to migrate Into the Int Ima.
can also produce endothel lal

High LDL levels

Injury due to the toxic

effects of oxidation products of I lpoprotelns upon
endothel Ium (Hennig & Chow, 1988).
amount of cholesterol

The Increased

In the blood which Is transcytosed

to macrophages may Induce them to produce the PDGF-1 Ike
mltogen, thus causing smooth muscle eel Is In the Int Ima
to prof Iferate.

However, cholesterol-laden macrophages

may cause smooth muscle eel I prof lferatlon Indlrectly by
Interposing themselves between endothel lal eel Is,
thereby exposing the subendothel Ium to the blood, and
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promoting the attachment and activation of platelets to
subendothel lal collagen; these activated platelet
aggregates WI I I then release PDGF (Ross, 1986).

THE ROLE OF PLATELETS IN ATHEROSCLEROSIS:
Many studies have shown that when the Intimal wal I
Is denuded of endothel lal eel Is, platelets wl I I attach to
the collagen fibers of the basal
activated, and wl I I degranulate.

lamina and become
Degranulatlon Indicates

the release of vesicle-bound substances such as
flbronectln, flbrlnogen, von WI I lebrand's factor,
thrombospondln, and PDGF.
also released.
ca++ levels.

Adenoslne dlphosphate (ADP) Is

ADP causes an Increase In lntracel Jular
An Increase In extracellular ca++ precedes

a plethora of reactions necessary for platelet shape
change, degranulatlon, and aggrega~lon.

One reaction

which occurs Is the calclum-calmodul In complex-dependent
formation of contract I le cytoskeletal proteins.

The

fl lamentous proteins are constructed from their globular
monomers already present In the cytoplasm within
approximately fifteen seconds of the lntracel lular Ca ++
Increase.

These contract I le proteins function In the

shape change reaction of activated platelets (Phi I I fps
et al, 1985).
A minimal

level of calcium Is also necessary for the

7

activation of the complex of glycoprotelns I lb and I I la.
This complex Is the membrane-bound adhesive receptor for
f I br I nogen.

When f I br I nogen b Inds th Is receptor,

It

faci I ltates platelet aggregation by binding one platelet
at each end of the molecule.

Platelet aggregates can

thereby be formed through the action of flbrlnogen I Inks
(Sless, 1989).
The normal physiological concentration of calcium Is
approximately 1 ml I I !molar (mM).

It has been found that

the extracellular concentration of free Ca ++ must be at
least 0.01 mM for maintenance of the glycoproteln I lbI I la complex.

Whl le the ADP-Induced Increase In

lntracel Jular Ca ++ ls necessary for the Initial
activation, extracellular levels below this minimal

level

are Inhibitory to the activity of the flbrlnogen receptor
(Shatt 11 & Brass, 1985).
The glycoproteln I lb-I I la complex Is also able to
bind to van WI I lebrand factor (vWF), an endothel lal eel I
protein released upon endothel Jal eel I Injury.

VWF binds

the glycoproteln complex at one end, and binds to
subendothel lal collagen at the other end.

The result Is

a platelet monolayer covering the denuded arterial wal I.
The adherance of platelets to the arterial wal I,
fol lowed by their aggregation and subsequent release of
PDGF,

Is be I I eved to be a major con tr I bu tor to
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atherogenesls.

It has been shown that when

thrombocytopenlc rabbits are exposed to endothel !al
Injury by angioplasty, there is no occurrence of
atherosclerosis (Hawlger et al, 1985).

It has not yet

been determined which factor produced by platelets Is
responsible for plaque production, but PDGF Isbel leved
to play a pivotal role (Steinberg,

1987).

Therefore the mechanisms of platelet activation
certainly must be explained.

In the hemostatlc capacity

of platelets, many factors are known to Interact.

When a

vessel wal I Is Injured, platelets first adhere to the
site of

Injury through vWF, then undergo a change of

shape.

As they aggregate through the action of

flbrlnogen,

they then degranulate (Sless,

1989).

Other

platelets which then pass by the Injury site may also
adhere to the vessel wal I and to each other.

The

formation of the hemostatlc plug Is often completed by
the production of a fibrin mesh which envelops the
platelets around the Injury site, thereby forming a blood
clot (Hawlger et al,

1985).

The development of the fibrin network Is dependent
upon the action of the prothromblnase enzyme complex
located on the membrane surface of platelets.
enzyme,

This

In Its active state, catalyzes the cleavage of

prothrombln to produce thrombln.

Thrombln

Is Itself an
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enzyme which catalyzes the conversion of flbrlnogen to
the protein fibrin (Sless, 1989).

The prothromblnase

complex consists of two protelnaceous subunits.

The

larger subunit Is Factor Va, a 16.8 kl lodalton
glycoproteln located on the surface of the platelet
membrane.
Factor Va (activated Factor V)

Is derived from

Factor V (Inactive), a blood-borne profactor.

It Is

cleaved by thrombln released by activated platelets to
produce Factor Va.

The activated Factor Va has a high

affinity for the platelet membrane surface, so It
attaches to platelets.

Once attached to the phosphol lpld

surface, Factor Va acts as a receptor for the other
prothromblnase subunit, a blood-borne enzyme cal led
Factor X.

Factor X, when activated by attachment to the

Va receptor, has an enhanced abl I Ity to cleave
prothrombln at two Identical amino acid sequences,
producing thrombln (Mann et al, 1985).

It has been found

that In hypercholesterolemlc rabbits, there Is a
significant amount of Factor Va located within the
the tissues of the aorta.

It has been hypothesized that

some physiological change which occurs as a result of
hypercholesterolemla causes smooth muscle eel Is to
produce Factor Va.

This Isolated aorta tissue from

hypercholesterolemlc rabbits has been shown to have
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significant Factor Va activity,

In that It can, upon

activation by thrombln or other vessel constituents,
catalyze the conversion of Factor X Into Factor Xa
(Rodgers et al, 1988).
The Increase of thrombln thus produced can have
several direct physiological effects.

As was Just

described, thrombln has enzymatic effects which activate
the prothromblnase complex, resulting In the production
of fibrin, which Is part of the hemostatlc response
cal led coagulation.
Thrombln also has a hormone-I Ike effect on
platelets.

Glycoproteln lb, a membrane-bound receptor on

platelet membranes, binds thrombln at one of thrombln's
non-enzymatic sites.
receptor,

When thrombln Is bound to this

It activates the adhesion receptors (receptors

for vWF and flbrlnogen) of platelets.

The exact

mechanism of action Is unclear, but an lntracel lular rise
In Ca++ occurs within 0.25 seconds of thrombln-lnltated
platelet activation (Sless, 1989).

As was previously

stated, the Increase In lntracel lular calcium Is
correlated with many of the reactions which occur In
platelet activation.

This lntracel lular rise In calcium

Is then responsible for

Increased activation of the

glycoproteln I lb-I I la complex (adhesion receptor) which
facl I ltates platelet aggregation through I lnkages with
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flbrlnogen.

Platelet aggregates often form at the site

of a vessel wal I Injury without Initiating the
coagulation process;

Instead, they wl I I become activated

at the Injury site, then begin to release PDGF (Sless,
1989).
Al I of these physiological

Interactions which have

been mentioned refer to the activities of platelets as we
understand them, both In hemostasls and In atherogenesls.
Much of what Is known about the pathogenesis of
atherosclerosis has resulted from the study of changes
which occur In the wal I of biochemically Injured
vessels.

There have also been many recent discoveries

concerning the effects of hypercholesteolemla upon
platelet activity.

Much of this work has shown that

platelets have an Increased tendency to undergo
aggregation and activation In hypercholesterolemlc
animals.

There are several mechanisms by which this

change In platelet activity Is thought to occur.
Cholesterol
membranes.

Is a natural constituent of plasma

Its presence within the membranes·

I lpld

bl layer acts as a control of the fluidity of the membrane
constituents.

Another major factor affecting fluidity Is

the fatty acid composition of membrane phosphol lplds.
According to Ross (1986),

Increased levels of blood

cholesterol may Induce the state of biochemical

Injury
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In endothel Jal eel Is by cholesterol's Increased

Infusion

Into their membranes, thus changing their fluidity and In
some way altering their biochemistry.
alteration has been found to occur

This type of

In platelet membranes.

Berl In et al

(1987) found that a high level of

blood cholesterol

In rabbits was associated with an

Increased level of cholesterol within the membranes of
their platelets, and a decrease In platelet membrane
fluidity.

Also associated with hypercholesterolemla Is a

change In the fatty acid composition of the platelet
membrane phosphol Ip Ids.

One of the most common changes

which occurs In hypercholesterolemlc animals' platelets
Is a reversal of the arachldonlc-to-olelc acid ratio
(Wlnocour et al,

1987).

Another way hypercholesterolemla may change platelet
activity Is by causing an alteration In the I lfe cycle of
platelets In circulation.

Megakaryocytes, the progenitor

eel Is of platelets which are located In bone marrow, have
been found

In hypercholesterolemlc rabbits to have an

Increased rate of turnover,

relative to control groups.

Based upon electron microscope studies of these eel Is,
the megakaryocyte population of the marrow of
hypercholesterolemlc rabbits exists at a mean state of
development which Is less than ful Jy mature (Dupont et
al,

1987).
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The change In fatty acid composition of platelet
membranes In hypercholesterolemlc rats Is positively
correlated with platelet Immaturity, and with Increased
platelet sensitivity to thrombln-medlated aggregation, as
measured by ADP luminescence aggregometry on Isolated,
washed platelets (Wlnocour et al, 1987).

The higher

sensitivity was correlated with an Increased level of
platelet aggregation on exposed subendothel lal wal Is.
This might be explained by the production of Factor Va by
the vessel wal I of hypercholesterolemlc animals.
So now there have been at least two categories of
circulatory components which have been Identified as
being altered In hypercholesterolemlc animals.
there Is the vesse I wa I I,

First,

In wh I ch near I y every ce I I type

of Its composition Is affected.

This change may first

occur at the level of the endothel lal

I In Ing of the

vesse I I umen, due to Increased I eve Is of cha I estero I In
eel I membranes (Ross, 1986), or due to the toxic effects
of oxidized LDL (Hennig & Chow, 1988).
known that,

However,

It Is

I ater, the smooth muse I e ce I Is and arter I a I

monocyte/macrophages play a role In the attraction of
platelets and as the major constituents of
atherosclerotlc plaques.

The mechanisms by which they

may cause platelet aggregates to form Involve at least
two pathways; exposure of subendothel lal collagen to the
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blood fol lowing rupture of the endothel lal

I In Ing, and by

the Increased activation of Factor X, resulting In the
production of more thrombln.
A second circulatory component which Is changed In
hypercholesterolemlc animals Is the blood platelet.

Its

membrane fatty acid and cholesterol composition Is
changed, and Its sensitivity to activation by thrombln Is
Increased.

The Increased sensitivity to thrombln may be

related to an enhanced thrombln-blndlng abl I lty
associated with hypercholesterolemla (Wlnocour et al,
1988).
However, the Increased sensitivity to thromblnmedlated aggregation was measured using Isolated, washed
platelets.

It has recently been found that In whole

blood, platelets have a higher Incidence of spontaneous
aggregation than they do when In Isolated platelet-rich
suspensions.

The Increased aggregation Isbel leved to be

mediated by the release of ADP by red blood eel Is; ADP,
which can activate the glycoproteln I lb-I I la complex,
Induces platelet aggregation In the presence of
flbrlnogen.

Red blood eel Is may also have some

undiscovered role In the Induction of platelet
aggregation related to their physical contact with
platelets (Sanlabadl et al, 1987).

Platelet aggregates

have also been seen In electron microscope studies to
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Include physical contacts with polymorphonuclear blood
ce I Is and monocytes ( Lehmann et a I , 1986) .
Of course, these eel Is are not the only components
of the blood which could possibly exert some Influence
upon platelet actions.

It Is conceivable that,

In whole

blood, there are many undiscovered Interactions between
blood eel Is and blood-borne molecules which Influence
platelet aggregation.

It would therefore be helpful to

our understanding of atherogenesls If platelet
sensitivity to aggregating agents In hypercholesterolemlc
and normal whole blood were Investigated.

RESEARCH HYPOTHESIS:

Platelets from hypercholesterolemlc animals,
compared to normocholesteremlc animals, demonstrate
Increased abl I lty to aggregate In whole blood, and this
Increased abl I lty to aggregate Is related to an Increase
In sensitivity of these platelets to thrombln.

QUESTIONS ASKED BY THE STUDY:

Do platelets In the whole blood of hypercholesterolemlc animals Increase In their abl I lty to
aggregate?

If so,

Is th Is change re I ated to an increased

sensitivity to thrombln?
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MATERIALS AND METHODS

DIETARY GROUPS:
The test animals were male Sprague-Dawley rats
obtained from Harlan Sprague Dawley Inc.

Each had an

Initial weight of 275 to 299 grams, which correlates to
an age of 65 to 72 days.
cages,

They were housed In Individual

17 X 18 X 35 cm, and I I lumlnated with artificial

I lght for 14 hours continually each day In the animal
room of Lappin Hal I at Morehead State University.
A control group of 10 rats was fed a normal diet of
Purina 5001 Laboratory Rodent chow, which Is cholesterolfree.

A high cholesterol diet group of 10 rats was fed

this diet for one week, then switched to a high
cholesterol

form of the Purina 5001 diet, obtained from

Bio-Serve (Frenchtown, NJ).

The high cholesterol chow

contained 5% cholesterol and 1% sodium taurocholate.
Rats are resistant to diet-Induced rises In blood
cholesterol

levels, and the addition of the bl le salt

sodium taurocholate Is used to facl I ltate the absorption
of cholesterol

In the Intestine (Wlnocour et al,

1988).

The high cholesterol diet was maintained for 8
weeks; Renaud et al,
on a

(1970) found that maintaining rats

I Ip Id-enriched diet for 5, 7, or 10 weeks was

sufficient for

Inducement of hypercholesterolemla.
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Platelets from rats eating these diets also showed an
Increased sensitivity to proaggregatory agents.

COLLECTION AND PREPARATION OF BLOOD SAMPLES:
The rats were anaesthetized with ether, and 4.5 ml
of whole blood was drawn from their tal I arteries, using
3 cc syringes with 22 guage, 1 Inch needles without
plungers.

Their tal Is were submerged In warm water for

two minutes prior to sampl Ing In order to di late the
arteries. (Bober, 1988).

·The blood was mixed with 3.2%

sodium citrate In a 9:1 ratio.

DETERMINATION OF PLASMA LIPl'D LEVELS:
Plasma was obtained by centrifugation In an Adams
CT-3200 Analytical Centrifuge at 3200 rpm for 5 minutes.
Total plasma cholesterol was measured using materials,
according to Sigma Diagnostics Procedure no. 352, which
Is a modification of the procedure described by Al fain et
al

(1974).

Absorbances of the samples at 500 nm were

measured In polypropylene cuvettes using an LKB Ultrospec
Spectrophotometer (Model 4050).

The sample absorbances

were compared to a blank, a 50 mg/di standard, a 250
mg/di standard, and a control sample with an elevated
level of I Ip Ids.
Plasma triglycerides were measured using the GPO-
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Trlnder method

(Procedure no. 339 of Sigma Diagnostics),

which Is a modification of the method described by
McGowan et al

(1983).

Absorbances of the samples were

read at 540 nm, then compared to a blank, a 250 mg/di
standard, and an elevated-I lpld control.
High-density I lpoproteln levels were measured
according to the HDL-Cholesterol Procedure no. 352-3 of
Sigma Diagnostics, a procedure designed by Warnick et al
(1982).

This procedure precipitated al I cholesterol

fractions except HDL-cholesterol, and the supernatant was
measured for cholesterol using the same procedure as was
described for the total cholesterol assay.
The plasma LDL fraction was then calculated from the
known total cholesterol, HDL, and triglyceride levels by
the formula CLDL = TcHOL - CHDL - TG/5, where CLDL Is the
low-density-I I protein cholesterol
total cholesterol

level, CHDL Is the hlgh~denslty-

1 lpoproteln cholesterol
level.

level, TcHOL Is the

level, and TG Is the triglyceride

This method has a 0.98 correlation coefficient

with results obtained by the ultracentrifugation method
of LDL-cholesterol measurement (Frledewald et al, 1972).
MEASUREMENT OF PLATELET AGGREGATION IN THE PRESENCE OF
VARIOUS THROMBIN LEVELS:
Platelet counts were performed on platelet-rich
plasma using a Coulter Counter, model ZF,

Platelet-rich
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plasma was derived from whole blood by centrifugation In
an Eppendorf 5415 centrifuge at 1100 rpm (200 x g) for 8
minutes.

Of this plasma, 6.66 mlcrol lters

was mixed

with lsoton I I diluent (Curtin Matheson Scientific,
In a 3000:1 di lutlon.
with

Inc.)

The Coulter Counter was cal lbrated

latex particles having a diameter of 0.2 microns,

and standardized with a Haem-PC platelet suspension
obtained from Baker

Instruments.

Measurement of platelet aggregation In whole blood
was performed In a Chrono-Log Whole Blood Aggregometer,
using the method described by Galvez, Badlmon, Badlmon,
and Fuster (1986).

Blood samples were prepared In a 1:1

mixture with calcium-free Tyrode solution, pH 7.4,

In a

modification of the method used by Russel I-Smith, Flower,
and Card Ina I ( 1988) .
The thrombln levels used were In the range of 0.1 to
0.6 units (0.1 to 0.6 micrograms) per ml of blood.
Thrombln was obtained from the Chrono-Log Corporation.

ANALYSIS OF DATA:
The relative frequencies of each group's response to
0.15 and 0.20 units of thrombln were expressed as
, percentages within each group.
maximal

rate of

The maxima I Impedance and

Impedance change were calculated for each

rat fol lowing responses to 0.15 units of thrombln.
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Within each group, these data were analyzed, and the mean
and standard deviation of the experimental group's
responses were compared to the responses of the control
group.

The nul I hypothesis was tested using the

student's t-test, and differences at the 0.05 level were
considered significant.
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RESULTS AND DISCUSSION

Plasma I lpld levels were altered by the addition of
5% cholesterol and 1% taurocholate to the diet of the
rats (Table 1).

Al I plasma I lpld levels, except

triglycerides, were altered slgnlflcantly.

Total

cholesterol and LDL were elevated, whl le HDL was lowered.

TABLE 1:
PLASMA LIPID LEVELS OF RATS FED FOR 8 WEEKS ON
A NORMAL DIET OR A HIGH CHOLESTEROL DIET CONTAINING 5%
CHOLESTEROL AND 1% SODIUM TAUROCHOLATE

Plasma
Lipid

N Diet Rats

HC Diet Rats

t-test

n

mg%

n

Tc

10

10.5 +/- 13.8

7

199.2 +/- 24.8

s

LDL

10

6.2 +/- 10.0

7

152.0 +/- 30.4

s

HDL

10

58.2 +/- 8.2

7

38.2 +/- 8.2

s

TG

10

48.9 +/- 15.9

7

44.2 +/- 16. 1

NS

mg%

mg% as mean, +/- standard deviation.
n = number of animals In diet group.
N = normal diet, HC = high cholesterol diet.
Tc = total cho I estero I , LDL = LDL cholesterol.
HDL = HDL cholesterol, TG = triglycerides.
s = significant at p < 0.05
NS = not significant at p < 0.05

There was no significant difference In platelet
counts of rats receiving the normal
cholesterol

(N) diet and high

(HC) diet for 8 weeks (Table 2).

22
TABLE 2: PLATELET COUNTS OF RATS FED FOR 8 WEEKS ON A
NORMAL DIET OR A HIGH CHOLESTEROL DIET CONTAINING 5%
CHOLESTEROL AND 1% SODIUM TAUROCHOLATE

Diet

n

N

7

107.705 +/- 48.124

10

101.090 +/- 25.855

Platelet counts In Ml I I Ions
Per -mL -of Whole
Blood
--~~

t-test

NS
HC

N = normal diet, HC = high cholesterol diet.
n = number In diet group.
Platelet counts as mean+/- standard deviation.
NS= not significant at p < 0.05.

The minimum amount of thrombln which Induced
aggregation In either group was 0.15 units (Figures 1 and
2).

Table 3 I I lustrates that the high cholesterol diet

group had a greater relative frequency (70%) of response
to the 0.15 units of thrombln compared to the relative
frequency (20%) of response by the normal diet group.
The relative frequency of thrombln-lnduced platelet
aggregation Increased In the high cholesterol diet group
of animals when the thrombln was Increased to 0.20 units
(Table 4).
Figures 1 and 2 I I lustrate typical thrombln-lnduced
aggregation responses In blood to 0.10, 0.15, 0.20, and
0.25 units of thrombln by the normal diet and high

cholesterol diet groups.

Aggregation responses were

measured by the maximal change In Impedance (maximum
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Figure 1: Aggregation responses of 1 mL blood (0.5 mL
citrated blood:0.5 mL Tyrode calcium-free buffer, pH 7.4)
from the normal diet group of animals to 0.15, 0.20, and
0.25 units of thrombin
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Figure 2: Aggregation responses of 1 mL blood (0.5 mL
citrated blood:0.5 mL Tyrode calcium-free buffer, pH 7.4)
from the high cholesterol diet group of animals to 0.10,
0.15, 0.20, and 0.25 units of thrombin
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TABLE 3:
RELATIVE FREQUENCIES OF PLATELET AGGREGATION
FOLLOWING ADDITION OF 0.15 UNITS OF THROMBIN TO BLOOD
FROM RATS FED FOR 8 WEEKS ON A NORMAL DIET OR A HIGH
CHOLESTEROL DIET CONTAINING 5% CHOLESTEROL AND 1% SODIUM
TAUROCHOLATE

Diet Group

n

Frequency of Aggregation

Percentage

N

10

2

20%

HC

10

7

70%

N
n

= normal diet, HC = high cholesterol diet.
= number In diet group.

TABLE 4:
RELATIVE FREQUENCIES OF PLATELET AGGREGATION
FOLLOWING ADDITION OF 0.20 UNITS OF THROMBIN TO BLOOD
FROM RATS FED FOR 8 WEEKS ON A NORMAL DIET OR HIGH
CHOLESTEROL DIET CONTAINING 5% CHOLESTEROL AND 1% SODIUM
TAUROCHOLATE

Diet Group

n

Frequency of Aggregation

Percentage

N

10

2

20%

HC

7

6

85.7%

N = normal diet, HC = high cholesterol diet.
n = number In ct.let group.

delta ohms), a tlme-lndepedent parameter, and by the
maximal rate of Impedance change (delta ohms per second),
which Is a time-dependent parameter.

When 0.15 units of

thrombln was tested on both groups, 8 out of 10 of the
normal diet group's blood samples had no response.
other norma I d I et samp I es on I y had s I I ght responses.

The
In
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the high cholesterol diet group, there were three blood
samples which showed no response, but the remaining 70%
of the high cholesterol diet group d~monstrated a
slgnlflcantly stronger response than any of those
el lclted by the same amount of thrombln units added to
the normal group's blood (Table 5).

TABLE 5:
THROMBIN-INDUCED AGGREGATION FOLLOWING ADDITION
OF 0.15 UNITS OF THROMBIN TO BLOOD FROM RATS FED FOR 8
WEEKS ON A NORMAL OR A HIGH CHOLESTEROL DIET CONTAINING
5% CHOLESTEROL AND 1% SODIUM TAUROCHOLATE

Diet Group

n

Delta Ohms/Sec

N

8

0.002 +/- 0.004

0.125

10

0.042 +/- 0.055

2.875 +/- 4.389

HC
t-test

Maximum Delta Ohms

P < 0.025

p

+/-

<

0.2673

0.05

N = normal diet, HC = high cholesterol diet.
Maximum Delta Ohms/Sec as means+/- standard deviation.
Maximum Delta Ohms as means+/- standard deviation.

Fol lowing 8 weeks of the high cholesterol diet, the
high cholesterol 'diet group had significant Increases In
both their total cholesterol
cholesterol

(mean 199 mg%) and LDL

(mean 152 mg%) plasma levels.

The Lipid

Research Cl lnlcs Program (1984) defines
hypercholesterolemla as a total cholesterol

level of over

240 mg% or an LDL cha I estero I I eve I of over 130 mg%.
Tyroler (1987) suggests that the level used as an
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Indicator of a risk of cardiovascular disease be lowered
to a p I asma tot a I cho I estero I I eve I of 160 mg%, based on
population statistics which show a steady Increase In the
r I sk of d I sease as cho I estero I I eve Is above th Is po Int
occur.

It Is very possible that even lower amounts of

plasma cholesterol than 240 mg% may produce
hypercholesterolemla-assoclated alterations In
circulatory physiology.
The high cholesterol diet group's mean HDL level
showed a significant decrease.

The pattern of an

Increase of LDL I eve I and a decrease of HDL I eve I Is an
Indication that the efficiency of the I lpld transport
mechanism of the high cholesterol diet animals has become
reduced.

This pattern normally occurs In

hypercholesterolemlc animals and humans due to downregulation of hepatic LDL receptors (Havel, 1987).
T~ls study has demonstrated that, associated with
these changes In blood I lpld levels In the high
cholesterol diet group, there Is an Increase In the
aggregation response of platelets to thrombln In whole
blood.
et a I

This certainly supports the discovery of Wlnocour
0
(

1988) , that I so I a ted, washed, hypercho I estero I em I c

platelets have a stronger binding affinity for thrombln
than normocholesterolemlc platelets.
The mechanism of thrombln activation of the adhesion
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receptor for flbrlnogen and vWF Is proposed to occur
through an lntracel lular rise In Ca++.

This rise Is
++
dependent upon the aval lab I I lty of extracellular Ca .
The anticoagulant used In this study (sodium citrate)
binds ionized calcium, preventing coagulation from
++
occurring. However, there must be a minimal Ca
concentration of 0.01 mM In the plasma for aggregation to
occur (Shatt I I & Brass, 1985).

To determine If the 3.2%

citrate decreased the plasma level of ca++ below 0.01 mM,
a sample of rat blood mixed In a 9:1 ratio with 3.2%
sodium citrate was analyzed In the cl lnlcal chemistry
laboratory at the University of Kentucky Medical Center.
The Ionized calcium level was found to be at a
concentration of 0.01 mM In whole blood, a level
sufficient to permit aggregation to occur.

The

measurement was performed using a calcium Ion-selective
electrode (Betty Mulberry, personal communication, July,
1989).
When thrombln-lnduced aggregation Is measured on
Isolated, washed platelets, sensitivity to thromblnlnduced aggregation Is Increased; this Increased
sensitivity Is correlated with a change In the fatty acid
content of platelet membranes, and with a reduced mean
platelet age and survival time.

Isolated, washed

platelets from hypercholesterolemlc animals do not
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demonstrate these changes after lnJectlon Into normal
rats,

Indicating that hypercholesterolemla-related

changes In platelet physiology are not Irreversible, but
are dependent on high cholesterol

levels (Wlnocour et al,

1987).
The study by Wlnocour et al

(1988) utl I I zed

change In I lght transmission as the measurement of
aggregation.

Change In I lght transmission as a

measurement of aggregation Is not feasible In whole
blood.

The washed,

Isolated, hypercholesterolemlc

platelets, compared to normocholesterolemlc platelets,
had a threshold level of response to thrombln-Induced
aggregation at 60 ng (0.12 units) and 90 ng (0.18 units)
of thrombln respectful Iy.

The specific reactivity of the

thrombln In the Wlnocour study was 2 units per microgram.
The Chronolog thrombln used In this study had a specific
activity of 1 unit per microgram.

The threshold levels

of response to thrombln-lnduced aggregation In this study
for the high cholesterol diet group, compared to the
normal diet group, was 0.15 units and 0.25 units of
thrombln, respectively.
Since hypercholesterolemlc animals' vessels may
produce Factor Va,

leading to the production of more

thrombln In the blood (Rodgers et al, 1988), there Is a
higher I lkel !hood of platelet aggregation at the vessel
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wal I of these animals If the platelet sensitivity to
thrombln

Is Increased In hypercholesterolemla.

This may

be one of the paths by which the risk of atherosclerosis
Is Increased by hypercholesterolemla.

\

f
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SUMMARY

Blood platelets are thought to contribute to
atherogenesls after they adhere and aggregate at sites of
the vessel wal I which have been either physically or
biochemically Injured.

Once platelet aggregates form at

the vessel wal I, they release PDGF, a growth factor which
stimulates the prol lferatlon of smooth muscle eel Is In
the vessel, resulting In a lesion which protrudes'lnto
the vessel

lumen and reduces the flow of blood to the

tissues downstream of the lesion.

Thrombln Is a protein

which can stimulate the aggregation of platelets at the
vessel wal I Injury sites, resulting In the production of
PDGF at these sites.
Platelets from hypercholesterolemlc animals,
compared to normocholesterolemlc animals, have been seen
In this study been seen to have a higher sensitivity to
thrombln-lnduced aggregation In whole blood.

This

supports the hypothesis that alterations In platelet
aggregation associated with hypercholesterolemla are a
part of the mechanism by which an Increased Incidence of
cardiovascular disease occurs.
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